{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T13:10:28Z","timestamp":1705929028971},"reference-count":51,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T00:00:00Z","timestamp":1703894400000},"content-version":"vor","delay-in-days":1093,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Particle Therapy"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.14338\/ijpt-20-00029.1","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T22:29:46Z","timestamp":1605306586000},"page":"11-23","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Simulation of an HDR \u201cBoost\u201d with Stereotactic Proton versus Photon Therapy in Prostate Cancer: A Dosimetric Feasibility Study"],"prefix":"10.1016","volume":"7","author":[{"given":"Jill S.","family":"Remick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pouya","family":"Sabouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren M.","family":"Bentzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeel","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.14338\/IJPT-20-00029.1_bib1","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.ijrobp.2010.10.075","article-title":"Dose-fractionation sensitivity of prostate cancer deduced from radiotherapy outcomes of 5, 969 patients in seven international institutional datasets: \u03b1\/\u03b2 = 1.4 (0.9-2.2) Gy","volume":"82","author":"Miralbell","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-20-00029.1_bib2","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0360-3016(98)00438-6","article-title":"Fractionation and protraction for radiotherapy of prostate carcinoma","volume":"43","author":"Brenner","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-20-00029.1_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0360-3016(01)01651-0","article-title":"A simple analytic derivation suggests that prostate cancer \u03b1\/\u03b2 ratio is low","volume":"51","author":"King","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-20-00029.1_bib4","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0360-3016(01)01607-8","article-title":"Is alpha\/beta ratio for prostate tumors really low?","volume":"50","author":"Fowler","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-20-00029.1_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ijrobp.2016.11.026","volume":"98","author":"Morris","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-20-00029.1_bib6","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.urology.2010.07.539","article-title":"Comparison of tumor control and toxicity outcomes of high-dose intensity-modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancer","volume":"77","author":"Zelefsky","year":"2011","journal-title":"Urology"},{"key":"10.14338\/IJPT-20-00029.1_bib7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bju.12514","article-title":"Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer","volume":"114","author":"Spratt","year":"2014","journal-title":"BJU Int"},{"key":"10.14338\/IJPT-20-00029.1_bib8","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2012.01.007","article-title":"Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer","volume":"103","author":"Hoskin","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.14338\/IJPT-20-00029.1_bib9","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1200\/JCO.2005.06.154","article-title":"Randomized trial comparing iridium implant plus external-beam radiation therapy with external-beam radiation therapy alone in node-negative locally advanced cancer of the prostate","volume":"23","author":"Sathya","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.14338\/IJPT-20-00029.1_bib10","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2018.0587","article-title":"Radical prostatectomy, external beam radiotherapy, or external beam radiotherapy with brachytherapy boost and disease progression and mortality in patients with gleason score 9-10 prostate cancer","volume":"319","author":"Kishan","year":"2018","journal-title":"JAMA"},{"key":"10.14338\/IJPT-20-00029.1_bib11","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.brachy.2016.12.015","article-title":"Brachytherapy boost for prostate cancer: trends in care and survival outcomes","volume":"16","author":"Glaser","year":"2017","journal-title":"Brachytherapy"},{"key":"10.14338\/IJPT-20-00029.1_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.brachy.2011.09.008","article-title":"American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy","volume":"11","author":"Yamada","year":"2012","journal-title":"Brachytherapy"},{"key":"10.14338\/IJPT-20-00029.1_bib13","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ijrobp.2016.12.024","article-title":"Continued benefit to rectal separation for prostate radiation therapy: final results of a phase III trial","volume":"97","author":"Hamstra","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-20-00029.1_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jmrs.224","article-title":"Initial experience with intra-fraction motion monitoring using Calypso guided volumetric modulated arc therapy for definitive prostate cancer treatment","volume":"64","author":"Bell","year":"2017","journal-title":"J Med Radiat Sci"},{"key":"10.14338\/IJPT-20-00029.1_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13014-016-0585-y","article-title":"Outcomes of hypofractionated stereotactic body radiotherapy boost for intermediate and high-risk prostate cancer","volume":"11","author":"Anwar","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.14338\/IJPT-20-00029.1_bib16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijrobp.2010.10.026","article-title":"Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: technique, early toxicity, and PSA response","volume":"82","author":"Jabbari","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-20-00029.1_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/153303461000900503","article-title":"A pilot study of intensity modulated radiation therapy with hypofractionated stereotactic body radiation therapy (SBRT) boost in the treatment of intermediate- to high-risk prostate cancer","volume":"9","author":"Oermann","year":"2010","journal-title":"Technol Cancer Res Treat"},{"key":"10.14338\/IJPT-20-00029.1_bib18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/153303461000900605","article-title":"Stereotactic body radiotherapy as boost for organ-confined prostate cancer","volume":"9","author":"Katz","year":"2010","journal-title":"Technol Cancer Res Treat"},{"key":"10.14338\/IJPT-20-00029.1_bib19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijrobp.2009.07.1689","article-title":"Hypofractionated boost to the dominant tumor region with intensity modulated stereotactic radiotherapy for prostate cancer: a sequential dose escalation pilot study","volume":"78","author":"Miralbell","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-20-00029.1_bib20","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.adro.2019.03.015","article-title":"Results of a prospective dose escalation study of linear accelerator\u2013based virtual brachytherapy (BOOSTER) for prostate cancer; virtual HDR brachytherapy for prostate cancer","volume":"4","author":"Eade","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.14338\/IJPT-20-00029.1_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2016.00114","article-title":"Intensity-modulated radiation therapy with stereotactic body radiation therapy boost for unfavorable prostate cancer: The Georgetown University experience","author":"Mercado","year":"2016","journal-title":"Front Oncol."},{"key":"10.14338\/IJPT-20-00029.1_bib22","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fonc.2017.00005","article-title":"Intensity-modulated radiation therapy with stereotactic body radiation therapy boost for unfavorable prostate cancer: a report on 3-year toxicity","volume":"7","author":"Paydar","year":"2017","journal-title":"Front Oncol"},{"key":"10.14338\/IJPT-20-00029.1_bib23","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.ijrobp.2019.04.006","article-title":"Stereotactic body radiation therapy boost for intermediate-risk prostate cancer: a phase 1 dose-escalation study","volume":"104","author":"Alayed","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-20-00029.1_bib24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijrobp.2019.09.039","article-title":"A multicenter phase 2 study of hypofractionated stereostatic boost in intermediate risk prostate carcinoma: a 5-year analysis of the CKNO-PRO Trial","volume":"106","author":"Pasquier","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-20-00029.1_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1088\/0031-9155\/44\/1\/014","article-title":"Intensity modulation methods for proton radiotherapy","volume":"44","author":"Lomax","year":"1999","journal-title":"Phys Med Biol"},{"key":"10.14338\/IJPT-20-00029.1_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/654861","article-title":"Hypofractionated proton boost combined with external beam radiotherapy for treatment of localized prostate cancer","volume":"2012","author":"Johansson","year":"2012","journal-title":"Prostate Cancer"},{"key":"10.14338\/IJPT-20-00029.1_bib27","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijrobp.2014.06.031","article-title":"Dose to the bladder neck is the most important predictor for acute and late toxicity after low-dose-rate prostate brachytherapy: implications for establishing new dose constraints for treatment planning","volume":"90","author":"Hathout","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-20-00029.1_bib28","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brachy.2005.03.005","article-title":"Combined modality treatment with high-dose-rate brachytherapy boost for locally advanced prostate cancer","volume":"4","author":"Hsu","year":"2005","journal-title":"Brachytherapy"},{"key":"10.14338\/IJPT-20-00029.1_bib29","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ijrobp.2006.04.045","article-title":"High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: results of a phase I to II study","volume":"66","author":"Vargas","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-20-00029.1_bib30","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ijrobp.2009.08.048","article-title":"Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321","volume":"78","author":"Hsu","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-20-00029.1_bib31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijrobp.2010.09.021","article-title":"High-dose-rate brachytherapy boost for prostate cancer: comparison of two different fractionation schemes","volume":"82","author":"Kaprealian","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-20-00029.1_bib32","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.ijrobp.2007.11.067","article-title":"CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations","volume":"70","author":"Fuller","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-20-00029.1_bib33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ijrobp.2012.03.035","article-title":"High-dose-rate prostate brachytherapy consistently results in high quality dosimetry","volume":"85","author":"White","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-20-00029.1_bib34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1590\/S1677-5538.IBJU.2014.0289","article-title":"Dosimetric coverage of the prostate, normal tissue sparing, and acute toxicity with high-dose-rate brachytherapy for large prostate volumes","volume":"41","author":"Yang","year":"2015","journal-title":"Int Braz J Urol"},{"key":"10.14338\/IJPT-20-00029.1_bib35","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.14338\/IJPT-20-00029.1_bib36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/0284186X.2016.1275781","article-title":"Hydrogel rectum-prostate spacers mitigate the uncertainties in proton relative biological effectiveness associated with anterior-oblique beams","volume":"56","author":"Underwood","year":"2017","journal-title":"Acta Oncol (Madr)"},{"key":"10.14338\/IJPT-20-00029.1_bib37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.semradonc.2018.02.009","article-title":"Concepts of PTV and robustness in passively scattered and pencil beam scanning proton therapy","volume":"28","author":"Langen","year":"2018","journal-title":"Semin Radiat Oncol"},{"key":"10.14338\/IJPT-20-00029.1_bib38","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1088\/0031-9155\/57\/13\/4095","article-title":"Comprehensive analysis of proton range uncertainties related to patient stopping-power-ratio estimation using the stoichiometric calibration","volume":"57","author":"Yang","year":"2012","journal-title":"Phys Med Biol"},{"key":"10.14338\/IJPT-20-00029.1_bib39","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.3109\/0284186X.2015.1061212","article-title":"A simulation study on proton computed tomography (CT) stopping power accuracy using dual energy CT scans as benchmark","volume":"54","author":"Hansen","year":"2015","journal-title":"Acta Oncol (Madr)"},{"key":"10.14338\/IJPT-20-00029.1_bib40","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ctrv.2013.10.006","article-title":"High dose rate brachytherapy boost for prostate cancer: a systematic review","volume":"40","author":"Zaorsky","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.14338\/IJPT-20-00029.1_bib41","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180010","article-title":"Comparing photon and proton based hypofractioned SBRT for prostate cancer accounting for robustness and realistic treatment deliverability","author":"Goddard","year":"2018","journal-title":"Br J Radiol."},{"key":"10.14338\/IJPT-20-00029.1_bib42","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijrobp.2013.05.022","article-title":"The influence of prostate volume on outcome after high-dose-rate brachytherapy alone for localized prostate cancer","volume":"87","author":"Le","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-20-00029.1_bib43","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brachy.2018.08.009","article-title":"Patient-reported health-related quality of life outcomes after HDR brachytherapy between small (<60 cc) and large (\u226560 cc) prostate glands","volume":"18","author":"Press","year":"2019","journal-title":"Brachytherapy"},{"key":"10.14338\/IJPT-20-00029.1_bib44","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0360-3016(02)03030-4","article-title":"Meta-analysis of rates of erectile function after treatment of localized prostate carcinoma","volume":"54","author":"Robinson","year":"2002","journal-title":"Int J Radiat Oncol"},{"key":"10.14338\/IJPT-20-00029.1_bib45","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.brachy.2014.04.003","article-title":"Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma","volume":"13","author":"Yamoah","year":"2014","journal-title":"Brachytherapy"},{"key":"10.14338\/IJPT-20-00029.1_bib46","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijrobp.2017.01.008","article-title":"ASCENDE-RT: an analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam boost for high- and intermediate-risk prostate cancer","volume":"98","author":"Rodda","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-20-00029.1_bib47","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.eururo.2008.06.048","article-title":"Characteristics of spontaneous activity in the bladder trigone","volume":"56","author":"Roosen","year":"2009","journal-title":"Eur Urol"},{"key":"10.14338\/IJPT-20-00029.1_bib48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2020.01.029","article-title":"Target motion mitigation promotes high-precision treatment planning and delivery of extreme hypofractionated prostate cancer radiotherapy: results from a phase II study","volume":"10","author":"Greco","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.14338\/IJPT-20-00029.1_bib49","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.radonc.2010.04.016","article-title":"Is there a role for endorectal balloons in prostate radiotherapy: a systematic review","volume":"95","author":"Smeenk","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.14338\/IJPT-20-00029.1_bib50","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ijrobp.2007.11.031","article-title":"Inter- and intrafractional movement-induced dose reduction of prostate target volume in proton beam treatment","volume":"71","author":"Yoon","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.14338\/IJPT-20-00029.1_bib51","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ijrobp.2015.12.366","article-title":"A prospective comparison of the effects of interfractional variations on proton therapy and intensity modulated radiation therapy for prostate cancer","volume":"95","author":"Moteabbed","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Particle Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518023001671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518023001671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/theijpt\/article-pdf\/7\/3\/11\/2772685\/i2331-5180-7-3-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/theijpt\/article-pdf\/7\/3\/11\/2772685\/i2331-5180-7-3-11.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T12:33:03Z","timestamp":1705926783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2331518023001671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2331518023001671"],"URL":"https:\/\/doi.org\/10.14338\/ijpt-20-00029.1","relation":{},"ISSN":["2331-5180"],"issn-type":[{"value":"2331-5180","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simulation of an HDR \u201cBoost\u201d with Stereotactic Proton versus Photon Therapy in Prostate Cancer: A Dosimetric Feasibility Study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Particle Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14338\/IJPT-20-00029.1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 \u00a9 2020 THE AUTHORS. Published by Elsevier BV on behalf of the Particle Therapy Co-operative Group. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}